share_log

HC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target

Benzinga ·  Mar 18 10:30  · Ratings

HC Wainwright & Co. analyst Patrick Trucchio reiterates Altimmune (NASDAQ:ALT) with a Buy and maintains $12 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 319

Recommended

Write a comment